Eur Rev Med Pharmacol Sci 2019; 23 (19): 8702-8704
DOI: 10.26355/eurrev_201910_19188

Editorial – Moving forward on the pathway of targeted immunotherapies for type 1 diabetes: the importance of disease heterogeneity

M. Infante, C. Ricordi

Diabetes Research Institute (DRI), University of Miami Miller School of Medicine, Miami, FL, USA. marcoinfante.md@gmail.com

Free PDF Download

To cite this article

M. Infante, C. Ricordi
Editorial – Moving forward on the pathway of targeted immunotherapies for type 1 diabetes: the importance of disease heterogeneity

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 19
Pages: 8702-8704
DOI: 10.26355/eurrev_201910_19188

Keywords Related articles:

  1. Blood glucose fluctuation aggravates lower extremity vascular disease in type 2 diabetes
  2. The role of adiponectin gene mediated by NF-κB signaling pathway in the pathogenesis of type 2 diabetes
  3. Remission of type 2 diabetes after bariatric surgery
  4. Association of ABO and Rh blood groups with type 2 diabetes mellitus
  5. Intramuscular islet allotransplantation in type 1 diabetes mellitus